Hormone replacement therapy in postmenopausal women and its effects on plasma lipid levels (Q34734554)

4 August 2017

1 reference

title

Hormone replacement therapy in postmenopausal women and its effects on plasma lipid levels (English)

1 reference

Hormone Replacement Therapy

4 August 2017

1 reference

Lúcia C N Erberich

1

1 reference

4 August 2017

Vânia M Alcântara

series ordinal

2

1 reference

4 August 2017

Geraldo Picheth

series ordinal

3

1 reference

4 August 2017

Marileia Scartezini

series ordinal

4

1 reference

4 August 2017

language of work or name

1 reference

1 May 2002

1 reference

Clinical Chemistry and Laboratory Medicine

4 August 2017

1 reference

4 August 2017

40

1 reference

4 August 2017

5

1 reference

4 August 2017

446-451

1 reference

Influence of bilateral oophorectomy upon lipid metabolism.

4 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Postmenopausal hormone therapy and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Atherogenicity of triglyceride-rich lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Differences in apolipoproteins and low-density lipoprotein subfractions in postmenopausal women on and off estrogen therapy: results from the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Effects of gemfibrozil on low-density lipoprotein particle size, density distribution, and composition in patients with type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Clinical equivalence of intranasal and oral 17beta-estradiol for postmenopausal symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Hormone replacement therapy and lipid-lipoprotein concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Lipid effects of hormone replacement therapy with sequential transdermal 17-beta-estradiol and oral dydrogesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Hormone replacement therapy and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Estrogen/progesterone replacement versus pravastatin and their sequential association in hypercholesterolemic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

Synergistic inhibition of LDL oxidation by phytoestrogens and ascorbic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.076

21 January 2018

Identifiers

DOI

10.1515/CCLM.2002.076

1 reference

4 August 2017

1 reference